10 results
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
11 Sep 23
Regulation FD Disclosure
8:01am
, reimbursement and value-based pricing (REGEN-016 & REGEN-008) 006 1st Registrational 016 2nd Registrational 015 Repeat dosing & Product Lifecycle 003 Label
424B3
PROK
ProKidney Corp - Ordinary Shares
9 Sep 22
Prospectus supplement
5:05pm
June 2007. Most recently, Dr. McKenzie served as Vice President, Medical, Global Head of Lifecycle Safety Project Leadership and Strategic Solutions from
DEFA14A
PROK
ProKidney Corp - Ordinary Shares
28 Apr 22
Additional proxy soliciting materials
4:33pm
of increasing responsibility since 2007. Most recently, she served as Vice President, Medical, Global Head of Lifecycle Safety Project Leadership
424B4
ajvgv 6vbaas0v
1 Jul 21
Prospectus supplement with pricing info
5:20pm
S-1
wzq1cjjvlrg r3471
2 Jun 21
IPO registration
5:17pm
DRS
3b4 zxwgdo3zvmut
21 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next